41 Although most literature demonstrates improvement of psoriatic lesions with GLP-1RA therapy, a randomized placebo-controlled trial showed lack of improvement with liraglutide in glucose-tolerant patients
Experimental and clinical studies have demonstrated reductions in systemic inflammatory markers such as C-reactive protein, IL-6, and tumor necrosis factor (TNF)- [9,25]
For many patients, this translates into easier portion control, fewer binges, and a more comfortable, gradual reduction in weight over time
This class of medications, including both long-acting and short-acting formulations, plays a crucial role in managing glycemic control and promoting weight loss. In recent years, the integration of telehealth services has further facilitated access to these therapies, allowing patients to receive care remotely